Abstract -We have compared /i-hexosaminidase (/J-Hex) activity, carbohydrate-deficient transferrin (CUT), mean corpuscular volume (MCV), y-glutamyltransferase (GGT), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) values in serum from male alcoholic patients with the corresponding values in moderate and non-drinking subjects. The total /J-Hex activity was 2.5 times higher in the alcoholics than in the moderate drinkers and this increase was mainly due to a 5-fold increase in the activity of the B-isoform of the enzyme. This was expressed as a percentage of the total /)-Hex activity and called '/?-Hex B%*. Strong correlations were found between alcohol consumption (g/ day) and j?-Hex B% (r = 0.757, P< 0.001, n = 42), alcohol consumption and CDT (r = 0.671, P < 0.001, n = 42), and 0-Hex B% and CDT (r = 0.628, P < 0.001, n = 57). Serums-Hex B% had a sensitivity of 94% and a specificity of 91% in detecting alcoholic drinking of >60g/day. As a single marker of alcoholic drinking, it was markedly more sensitive than MCV and the liver enzymes GGT, AST and ALT, and slightly more sensitive than serum CDT (94 vs 83%). At the CDT cut-off level of 20 U/l, 17% of the moderate and non-drinkers would have been classified as alcoholic drinkers and 17% of the alcoholics would have been classified as moderate drinkers. Some of these misclassifications were eliminated if the /f-Hex B% results were taken into account We suggest that serum /J-Hex B% can be a useful and inexpensive laboratory test for alcohol abuse.
INTRODUCTION
Carbohydrate deficient transferrin (CDT) is becoming widely accepted as the best indicator of chronic alcohol abuse. It has proved to be more sensitive and specific as a marker of alcohol abuse than the traditionally used tests routinely available in clinical laboratories, i.e. mean corpuscular volume (MCV) and serum activities of the liver enzymes y-glutamyltransferase (GGT), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (for a review, see Stibler, 1991; Allen et al, 1994) . The major drawback of CDT is that commonly used methods for its quantification are elaborate, involving gel or column chromatography, and commercial test kits are also expensive.
Increased serum and urine activities of the
•Author to whom correspondence should be addressed at Institute of Environmental Science and Research Ltd (ESR), PO Box 30547, Lower Hutt, New Zealand. lysosomal enzyme /Miexosaminidase (/?-Hex, also called N-acetyl-£-glucosaminidase, E.C. 3.2.1.30) were put forward as markers for chronic alcohol abuse several years ago (Hultberg et al, 1980; Isaksson et al, 1985; Martines et al, 1989; Karkkainen, 1990; Karkkainen et al, 1990a) . Although /?-Hex has not been as widely studied as CDT as a marker for excessive drinking, it has been shown that its activities in serum and urine are significantly increased in alcoholics as well as in healthy volunteers after recent drinking of >60g of alcohol for at least 10 days (Hultberg et al, 1980; Karkkainen et al, \990b; Hultberg et al, 1991; Wehr et al, 1991) . 0-Hex is present in several isoforms in most tissues, and the major forms are commonly denoted as A, B, I and P (Price and Dance, 1972; Mahuran et al, 1985) . Hultberg et al (1995) recently suggested that increased serum activity of isoforms B + I + P (denoted as 'B') may be a more sensitive marker for alcoholic drinking than CDT. The /?-Hex activity can be measured by fluorimetric and spectrophotometric methods using inexpensive reagents. This makes it easily accessible for routine use. Furthermore, the activities of the major isoforms can be distinguished by a simple heat treatment because isoform A is heat sensitive while 'B' isoforms are heat-stable (Price and Dance, 1972; Mahuran et al., 1985) .
In the present study, we have measured the heat-stable and heat-labile activities of serum and urine /?-Hex from different drinking groups and compared the effectiveness of this enzyme in detecting alcohol drinking with that of CDT, MCV, GGT, AST and ALT. We also looked at whether better sensitivities and specificities can be obtained by a combination of markers than with the individual markers alone.
SUBJECTS AND METHODS

Subjects
All subjects gave their informed consent to participate in this study which was approved by the Ethics Committee of the Central Regional Health Authority, Wellington, New Zealand. All alcoholic and control subjects were males.
The 18 alcoholic subjects voluntarily entered an alcohol and drug detoxification unit at a local hospital over a period of 9 months. They had been drinking heavily for at least the preceding 2 weeks and their self-declared alcohol consumption during this time ranged from 120 to 300g/day. They were all classified as 'alcoholics' by a clinician specializing in the treatment of alcoholics (G.M.R.). The patients were routinely breathalysed to estimate their level of intoxication and blood and urine samples were taken (sample 1) on their arrival at the hospital. The blood alcohol level at arrival ranged from 9 to 109 mmol/1 (49 ± 26 mmol/1, mean ± SD). Further blood and urine samples were taken after the blood alcohol had fallen to ~6 mmol/1 [between 2 and 19 h (8.0 ± 5.3 h) after arrival] (sample 2) and between 28 and 112h (65 ± 32 h) after arrival (sample 3). CDT was measured in samples 1 and 2 and /J-Hex was measured in samples 1, 2 and 3. When the patients were sober, they were interviewed by their nurse or doctor and informed consent to participate in the study was sought. The interview on their general alcohol drinking habits was based on the AUDIT questionnaire (Alcohol Use Disorders Identification Test) developed under the auspices of WHO (Saunders et al., 1993) . They were also asked about the length of the drinking period preceding their hospitalization, the amount of alcohol consumed, and their health, medication and illicit drug use. Multidrug users and patients with mental disability were excluded from the study. No patients included in the study had clinical signs of liver damage. Biochemical signs of liver damage were indicated by their GGT, AST and ALT measurements. None of the patients included in the study had medical conditions which could have affected /?-Hex, such as diabetes or renal failure, and none was treated for hypertension at the time of admission. However, some of the patients developed transient hypertension during the alcohol withdrawal period.
The moderate drinkers and non-drinkers were volunteers consisting of laboratory staff and other personnel in our institute (E.S.R.) and their friends. They were also studied over a 9-month period and an attempt was made to have similar age composition to the patients. All subjects in these groups were healthy and not on any regular medication. The alcohol consumption of the drinkers was assessed by the AUDIT questionnaire and by a 2-week drinking diary which the subjects completed prior to the blood and urine sampling. On the basis of the 2-week drinking diaries, the drinkers who consumed <60g/day were classified as moderate drinkers (n = 20) and those who consumed >60g/day were classified as heavy 'non-alcoholic' drinkers (n = 4). The moderate drinkers consumed alcohol, on average, on 4 days per week during the last fortnight and on average 34 g during the day prior to blood sampling. The heavy drinkers had consumed alcohol for 4-5 days per week, and during the day prior to blood sampling they had consumed 74-112 g of alcohol.
The size of the heavy drinking group (n -4) was too small to be used for any significant statistical test. Fifteen subjects recruited as 'non-drinkers' declared drinking very rarely and, if drinking, consumed no more than two drinks per occasion a few times a year.
Unlike blood and urine samples 1 and 2 from the patients, neither the moderate drinkers nor the heavy drinkers had any alcohol in their blood or urine samples. However, comparisons of the samples from these groups were justifiable, because we did not see any effect of alcohol in vitro up to a sample concentration of 100mmol/l on either CDT or /J-Hex in serum and urine samples (results not shown).
Analytical methods
Blood and urine samples. To obtain serum, blood samples were taken into plain Vacutainer tubes and allowed to clot at 4-8°C overnight. Serum was separated by centrifugation and analysed for GGT, AST and ALT activity. Serum for CDT and £-Hex was stored at -70°C until analysis. For MCV measurements, blood was taken into a Vacutainer containing EDTA and MCV was measured on the same day. Urine samples were collected and stored at 4-8°C for up to 12 h. After centrifugation, the samples were stored at -70°C until analysis.
CDT. Serum concentrations of CDT were measured using the CDTect™ kit from Pharmacia (Kabi Pharmacia Diagnostics, Uppsala, Sweden) within 3 months of storage at -70°C. This method is based on separation of CDT by anion exchange chromatography in a microcolumn, followed by radioimmunoassay (RIA) for transferrin quantification in the eluate (Stibler et ai, 1986) . The kits used were the latest prototype and the anion exchange separation was based on ionic strength, not on pH as in the earlier kit (Stibler et ai, 1991) .
Approximately half of the samples were analysed in duplicate, with good agreement between the duplicates. Intra-assay coefficients of variation (CV) were always < 10% and usually <5%. The assay kit contains 50 micro-columns, reagents for iron saturation of the serum and for the RIA of CDT, quality control serum and transferrin standards for the calibration curve. The CDT concentration is expressed as units per litre (U/l) calculated from the RIA transferrin calibration curve. Day-to-day assay accuracy was monitored using the quality control serum provided by the manufacturer and an additional inhouse quality control serum sample. The latter was prepared by incubating 1 ml of serum from a healthy individual with 1 unit of Vibrio cholera neuraminidase (BDH Chemicals, Poole, UK) at 37°C for 12 h to desialize transferrin. Different dilutions of the desialized serum were then applied to the microcolumns and the transferrin in the eluate was quantified by radioimmunoassay. A semi-log plot of the dilution factors versus response was linear up to 250 U/l. Aliquots of 1:10 dilution of the desialized serum were stored at -70°C and analysed in each batch. The CV obtained from five assay batches was 15% (mean ± SD; 67 ± 10 U/l). The interassay CV for the manufacturer's quality control sample was 4.2% (19 ± 0.8 U/l). Approximately half of the serum samples in this study were analysed in duplicate in the CDT assay. The positive-negative cut-off value (the upper reference limit) recommended by Pharmacia is 20 U/l for males, based on their finding that 98% of male subjects drinking <15 g/day have CDT values <20 U/l.
fi-Hex. Serum and urine /?-Hex activities were measured as described by Skrha et al. (1987) with a few adaptations. Serum and urine were diluted 1:10 in 55 mM citric acid buffer, pH 4.4, containing 0.85% (w/v) NaCl and 0.1% human serum albumin (Fraction V, Sigma Chemical Co., St Louis, MO, USA). A proportion of these dilutions were heated in a shaking water bath at 50°C for 2 h to destroy the activity of the heat-labile A isoform of j9-Hex (Price and Dance, 1972) . No further inactivation of the enzyme was obtained by increasing the incubation time over 2 h. Portions (250 jo/1 each) of the 'heated' and 'unheated' samples were incubated in disposable cuvettes in a shaking water bath at 37°C with 250 \i\ of 100 mM substrate solution (p-nitrophenyl-N-acetyl-^-Dglucosamine from Sigma, in 50 mM citric acid buffer, pH 4.4; the final concentration of the substrate in the cuvette was 50 mM in 50 mM citrate buffer at pH4.4). Serum samples were incubated with the substrate for 30 min and urine samples for 60 min. The enzyme-catalysed reaction rates in serum and urine samples were linear for at least up to 2.5 h of incubation with the substrate concentration used. The reaction was terminated with 500 ul of 0.2 M carbonate buffer, pH 10.4. Each sample was measured in duplicate together with its own single 'blank' containing 250 |il of the sample. The blanks were incubated together with the samples and at the end of the incubation 500 ul of the carbonate buffer and 250 ul of the substrate solution were added to them. The reaction product (p-nitrophenol) in the samples was measured by spectrophotometry at 405 nm against their own blanks. The absorbance value of the samples was compared with the absorbance of the p-nitrophenol standard which was incubated under the same conditions as the samples (250 ul of 100 mM p-nitrophenol, diluted from a lOmM solution obtained from Sigma, incubated with 250 ul of the substrate solution and 500 ul carbonate buffer added). Calculated from this standard, the molar absorption coefficient for the p-nitrophenol ion was 18.1 ±0.4M~'cm~l (mean ± SD of 19 separate assays). Absorbance was linear for at least up to 600 mM p-nitrophenol.
One enzyme unit was defined as the amount of the enzyme that converts 1 mmol of substrate/min into p-nitrophenol at 37°C and it was calculated from the formula:
sample absorbance x 100 mM x sample dilution factor standard absorbance x min of incubation = U/min/1
The activity in the 'heated' sample was defined as the activity of 'B' and consisted of activities of the heat-stable /J-Hex isoforms B, I and P (Mahuran et al., 1985) . Urinary /J-Hex activities were expressed in relation to creatinine (Wellwood et al., 1976) . A 1:10 dilution of urine prior to the enzyme assay was sufficient to eliminate the influence of inhibitors in the urine (Wellwood et al., 1976) . We found that 95-100% of the spiked /7-Hex preparation (N-acetylglucosaminidase from bovine kidney, Sigma) was recovered from urine samples diluted 1:5 while only 85% was recovered from undiluted urine samples.
All blood and urine samples were measured within a month of storage at -70°C. A separate storage experiment showed that /?-Hex activity in serum appeared to fall by ~4% under these storage conditions (decrease of 4.1 ± 1.5%, n = 7). Quality control samples were included in each assay batch in order to assure the inter-assay reproducibility and further observe the effect of storage on /?-Hex activity. p*-Hex (N-acetylglucosaminidase) from bovine kidney (Sigma) was added to 0.1% human serum albumin and serum and urine from a single donor, to concentrations of 8 and 16 U/l. Aliquots of these were stored frozen at -70°C together with the samples and measured with each assay batch. No significant changes in enzyme activities were found in serum, urine or in 0.1% HSA measured at different times during their 3 month storage (Table 1) . Based on the analysis of these samples, the intra-assay coefficient of variation was <5% for the 'unheated' and < 10% for the 'heated' samples.
Liver enzymes and MCV. Serum and urine creatinine, and serum activities of AST, ALT and GGT were assayed by standard clinical laboratory methods in the laboratory of the patients' hospital. MCV was measured by Coulter counter (Coulter S/+ Junior) using a commercial quality control preparation (Paral2, Strick Lab., Inc., Omaha, NE, USA). Based on local population studies, the normal values for AST, ALT, GGT and MCV used by the hospital were 40, 48 and 63 U/l, and 98 fl respectively. For the purpose of this study, the values 35, 48, 63 and 93, for AST, ALT, GGT and MCV respectively were used as cut-off values when calculating specificity and sensitivity of these markers to detect alcoholic drinking. These cut-off values were chosen to give ~90% specificity.
Statistical analyses
The results are given as means ± SD. The relationships between alcohol consumption and each marker value and the relationship between two different markers were evaluated by Spearman rank order correlation (r). The significance of differences between the marker values in the alcoholic group compared to the marker values in the moderate drinking group was determined using the Wilcoxon rank sum test.
The diagnostic efficiency of the markers was evaluated by determining sensitivity, specificity and accuracy in detecting alcoholic drinking of >60g/day. The four heavy social 'non-alcoholic' drinkers were not included in these calculations. Sensitivity was calculated as the number of true positives (alcoholics drinking >60g/day with the marker value above the cut-off) as a percentage of the 18 alcoholic drinkers drinking >60g/day. Specificity was calculated as the percentage of the true negatives (individuals in the moderate and non-drinking groups who drank ^60g/day and whose marker values were equal to or below the cut-off levels). The overall accuracy (efficiency) was expressed as the proportion of correct classifications based on the marker results, i.e. the number of true positives plus the number of true negatives divided by the total number of cases.
Receiver-operating characteristic (ROC) curves (Hanley and McNeil, 1983) were also used in test performance evaluation. Values are mean ± SD. n refers to number of times samples were assayed during the 3 month period of storage at -70°C. * /?-Hex was the enzyme preparation (A/-acetylglucosaminidase) from Sigma (see Materials and Methods). b /J-Hex B activity in this preparation was so low that it could not be accurately measured by our method. HSA = human serum albumin. Serum and urine were from a single donor.
RESULTS
The mean (±SD) and the range of age, AUDIT score, alcohol consumption and the values of the traditional markers, MCV, GGT, AST and ALT are given in Table 2 . The range and the mean of the ages of the individuals in the different groups were very similar, as attempted by the priori agematching.
The alcohol drinking of the moderate drinkers, based on their 2 week drinking diary, ranged from 2 to 48 g/day and that of the heavy drinkers ranged from 67 to 112 g/day. The frequency of drinking and average daily consumption estimated from the diaries were fairly consistent with the. responses to the first three questions in the AUDIT questionnaire, which relate to the amount and frequency of average consumption. AUDIT scores for the moderate drinkers varied from 2 to 16 and for the four heavy drinkers from 10 to 12. Six out of 20 moderate drinkers had art AUDIT score >8 which, according to Saunders et al. (1993) Values are means ± SD, with range in parentheses. *** P < 0.001, ** P < 0.01, vs the moderate drinkers with the Wilcoxon rank sum test. * Full AUDIT questionnaire was not applied to the non-drinkers. MCV = mean corpuscular volume; GGT = y-glutamyltransferase; AST = aspartate aminotransferase; ALT = alanine aminotransferase. Values are mean ± SD, with range in parentheses, n = number of subjects analysed in each group. In the alcoholic group, serum sample 1 was taken within 1 h of admission to hospital, samples 2 and 3 were taken, on average, 8 h and 65 h (3 days) after admission, respectively (see Materials and Methods). ••• P < 0.001, *• P < 0.01, vs the moderate drinkers with the Wilcoxon rank sum test. considered as an indication of 'hazardous' drinking. However, all of these had marker values below the cut-off levels, except for one subject whose CDT value was above the cut-off and another subject whose GGT value was above the cut-off. The AUDIT scores of the alcoholics, ranging from 16 to 38, were significantly higher than the AUDIT scores of the moderate drinkers (P < 0.001). There was a highly significant correlation
between alcohol consumption and serum CDT, alcohol consumption and the total /?-Hex activity and alcohol consumption and /?-Hex B% in the three drinking groups (r values were 0.671, 0.669 and 0.757, respectively, with P < 0.001, n = 42). The correlations between alcohol consumption and the activities of GGT, AST and ALT were also highly significant (r = 0.589-0.683, P < 0.001, n = 42). The correlation between alcohol consumption and MCV was poorer, but still statistically significant (r= 0.380, P<0.01, n = 41).
In the alcoholics, the values for MCV and the activities of GGT, AST and ALT were all significantly higher than those in the moderate drinkers (P = 0.05-0.001, Table 2), although there was a considerable overlap in values and the alcoholics showed a large range in their values.
The alcoholics had significantly higher CDT levels in both sample 1 (the sample taken on arrival at the hospital) and sample 3 (taken ~3.3 days after arrival, see 'Subjects' in Materials and methods) than the moderate drinkers (P < 0.001, Table 3 ). The 14% decrease in the CDT values during the 3.3 days of abstinence is consistent with the estimated 10 day half-life of increased CDT in excessive drinkers (Stibler, 1991) .
The mean of the total /?-Hex activity in the serum sample 1 from the alcoholics was ~ 2.5-fold higher than the corresponding mean in the moderate drinkers (Table 3 ). Figure la shows that this increase was mainly due to the increase in the activity of the B form of the enzyme, which was 5-fold higher than the level in the moderate drinkers. Whereas in the moderate and nondrinkers the B form activity was less than the activity of the A form, in alcoholics the activity of the B form increased proportionately more than the A form activity, resulting in a reversal of the ratio of A to B forms.
The correlation between serum /?-Hex B% and CDT in the whole study population was highly significant (sample 1, r = 0.628, P < 0.001, n = 57).
The increase in the urinary /?-Hex activity in the alcoholics was mainly due to an increase in the activity of the A form of the enzyme (Fig. lb) . However, these changes in urinary ^-Hex were not statistically significant
After an average of 3.3 days of abstinence in hospital (sample 3, Table 3 ) the total /?-Hex and /?-Hex B activities, although still significantly higher than in the moderate drinkers (P < 0.01), had decreased by 33 and 48%, respectively (means of samples 3 vs means of sample 1, Table 3 ). Measurements of serum creatinine levels in samples 1 and 3 showed that this decrease in /?-Hex was not simply due to correction of the dehydration state after a long period of drinking. The decreases in these /?-Hex values were seen in all patients and there was no correlation between the change in the serum creatinine levels and the decrease in the /?-Hex values (creatinine levels in sample 1: 81 ± 17 mmol/1; sample 3: 95 ± 34 mmol/1). The rapid decrease in the /?-Hex activity therefore indicates a short halflife of the order of 3-4 days for the increased /?-Hex B activity.
No significant differences between the moderate drinkers and non-drinkers were found for any of the marker values (Tables 2 and 3 ). The group of heavy drinkers {n = 4) was considered too small for statistical comparison of the means.
Sensitivities (true positive rates) and specificities (true negative rates) in detecting alcoholic drinking of > 60 g/day at a given cut-off value for each marker and for some of their combinations are given in Table 4 . Table 4 shows that with the traditional markers, MCV, GGT, AST and ALT, if high specificity is preferred (90-100%) sensitivity is unacceptably low (50-67%), decreasing the overall accuracy (percentage of correct identifications) to 75-85%. For CDT, at the commonly used cut-off level of >20U/l (Stibler, 1991) , the sensitivity and specificity are 83% and 86%, respectively. The /?-Hex B% seemed to be slightly better as a single marker than CDT in this study. When > 35% B-form activity was used as the cutoff value, a specificity of 91% and a sensitivity of 94% were obtained.
The ROC plots in Fig. 2 illustrate the performance of CDT and /?-Hex B as diagnostic tests for alcoholic (> 60 g/day) drinking across the spectrum of possible cut-off values for CDT and /J-Hex B%. They illustrate how sensitivity changes in relation to specificity when the cut-off values are increased or decreased. The ROC curve for /?-Hex B%, which is higher and more to the left than the curve for CDT, indicates slightly better test performance than CDT. Table 4 also shows how sensitivities and specificities change when a combination of two Total n = 53, consisting of 18 alcoholic drinkers drinking >60g/day, 20 moderate drinkers drinking <60g/day, and 15 non-drinkers (see Materials and methods). Abbreviations: see Tables 2 and 3. tests is used. Two approaches can be taken in combining two tests: an individual is regarded as having a positive test if (1) both tests are above the cut-off value ('both/and' approach), or (2) either one or the other test is above the cut-off value ('either/or' approach). As the 'both/and' approach sets a more strict criterion for true positives it gives lower sensitivity but higher specificity than either of the two tests alone (Table 3 ). The 'either/ or' approach, on the other hand, increases the sensitivity but can decrease the specificity.
DISCUSSION
We have shown that the increased serum /?-Hex activity in heavy alcoholic drinkers is mainly due to the increased activity of the heat-stable isoforms, which include isoforms B, I and P (isoform 'B' in our study). This increased /?-Hex B activity, when expressed as % of the total activity, was clearly more effective than the traditional markers of alcohol abuse, MCV, GGT, AST and ALT, in distinguishing alcoholic drinkers from moderate and non-drinkers in our study population. With a sensitivity of 94% and a specificity of 91%, it was also slightly more effective than CDT, which showed an 83% sensitivity and an 86% specificity. These findings are consistent with those of Hultberg et al. (1995) . Using an enzyme immunoassay method for the measurements of /?-Hex activity in serum, these authors found the increased total units of /?-Hex B (B + I + P isoform) activity slightly better than CDT in detecting heavy alcoholic drinking. We have demonstrated that a simple heat treatment used to distinguish the activities of the two major categories of /?-Hex can be used to obtain the same result.
/?-Hex B therefore appears to be as good as CDT in detecting heavy alcoholic drinking. CDT, however, has been shown not to be very effective in detecting less excessive but still harmful drinking in unselected populations (Nilssen et al, 1992; Sillanaukee et al, 1994; Gr0nbak et al, 1995) and it remains to be shown whether or not /?-Hex B activity has a similar deficiency as a marker of alcohol consumption. A study on young university students suggests that it may be so (NystrOm et al., 1991) . However, in this study only the total /?-Hex activity was measured.
A drawback of /?-Hex as a marker of excessive drinking is that, unlike CDT, which is not increased in many conditions other than regular heavy drinking (Allen et al., 1994; Stibler, 1991) , serum )9-Hex can be increased by a number of conditions not related to alcohol use, such as hypertension, diabetes mellitus, liver cirrhosis, myocardial infarction, cerebral infarction, pregnancy and possibly also atherosclerosis (Pitkanen et al., 1980; Hultberg and Isaksson, 1983; Mahuran et al., 1985; Isaksson and Hultberg, 1989; Hultberg et al., 1994 Hultberg et al., , 1996 . Therefore, the specificity of /J-Hex as a single marker of alcohol abuse could be greatly reduced if the study population includes non-drinking subjects with these conditions.
One little-used approach to confront the problems with specificity of /?-Hex is to use it in combination with other markers which are not affected by as many of the same conditions as £-Hex, such as MCV, GGT or CDT. In this paper, we have given examples of the effects of two types of combination of markers on specificity and sensitivity. When combining two (or more) markers, the criterion for a positive test could be set in two ways. For a test to be 'positive', both marker results may be required to be above their cut-off levels ('bom/and' approach). Alternatively, either of the marker values could be above its cutoff ('either/or' approach). The 'both/and' approach offers a more strict criterion for true positives, and consequently reduces the number of true positives (decreases sensitivity) but it also reduces the number of false positives (increases specificity). This approach may be preferred when more confidence is needed for the classification of an individual as an alcoholic. The 'either/or' approach, on the other hand, offers a more loose criterion for true positives, and consequently the number of true positives increases (the sensitivity increases) but the number of false positives can also increase (specificity decreases).
In the present study with the 'either/or' approach, the combination of /?-Hex B% and CDT gave 100% sensitivity, which was higher than with either marker alone, and the 'both/and' approach gave higher specificity than either marker alone. Similar results were obtained with the £-Hex B% combined with MCV or GGT. While the sensitivity of MCV and GGT alone is very low (50 and 53%, respectively), when combined with /?-Hex B% using the 'either/or' approach sensitivity increased to 94-100%, and with the 'both/and' approach, their specificities increased to 97-100%. We therefore suggest that the combination of two (or more) markers can be more useful than any of the markers alone in classifying an individual's drinking status, and depending on the marker and whether high sensitivity or high specificity is required, the 'either/or' or 'both/and' approach can be used.
In conclusion, serum /?-Hex B% may be a useful, convenient and inexpensive laboratory test for alcoholic heavy drinking. More studies on /?-Hex B in unselected populations, and populations with conditions known to affect /?-Hex B, are needed to further assess its value as a marker of harmful drinking.
